Latest Regulatory News

Althea Group Holdings reported a 20% increase in customer receipts to $9.01 million for Q2 FY25, while addressing governance lapses and reviewing its FY25 guidance. The company is advancing operational improvements and cost savings as it prepares for a pivotal Federal Court hearing.

Echelon Resources delivered a robust Q4 2024, driven by standout drilling results at Mereenie and a 23% rise in Amadeus production receipts, underpinning a strong financial position.

Superior Resources Limited reports significant progress in its Steam Engine Gold Project and Bottletree Cu-Au-Mo Porphyry Prospect, while addressing assay errors that have delayed some results.

Geopacific Resources has successfully raised $40 million through a renounceable entitlement offer to advance its 1.67 million ounce Woodlark Gold Project, with a major drilling campaign and updated feasibility study planned for 2025.

Aeris Environmental Ltd reported a 5% revenue increase to $766,000 in the December 2024 quarter, driven by strong margins and momentum in its AerisTech joint venture. The company’s expanding customer base and strategic partnerships signal promising growth in smart building solutions and consumables.

Aguia Resources has commenced underground mining at its Santa Barbara gold project and secured a key court victory for its Brazilian phosphate project, supported by a $1.5 million capital raise.

AustChina Holdings Limited has requested a voluntary suspension of its shares as it prepares to announce a significant acquisition, extending a prior trading halt to ensure orderly disclosure.

Jervois Global Limited has entered a pivotal recapitalization agreement with Millstreet Capital Management, involving a US$145 million equity injection and a pre-packaged Chapter 11 bankruptcy process. The company aims to strengthen its balance sheet and continue operations uninterrupted while preparing for a strategic restart of its nickel-cobalt refinery in Brazil.

First Lithium Limited reports promising metallurgical testwork results and an imminent maiden Mineral Resource Estimate, underpinning its Mali lithium projects amid ongoing license renewal progress.

DigitalX Limited reported a 15% revenue increase in Q4 2024, driven by staking activities and performance fees, alongside a $10.3 million private placement and strategic Solana investment. The DigitalX Bitcoin ETF surpassed $50 million in funds under management, delivering a 67.4% quarterly return.

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

Prescient Therapeutics has secured FDA clearance to initiate its Phase 2 PTX-100 trial for relapsed cutaneous T-cell lymphoma, alongside progress in its cell therapy platforms and a solid cash position bolstered by a recent R&D rebate.